Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-03-28

FDA Approved: MOTOFEN — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MOTOFEN (difenoxin and atropine sulfate) submitted by Legacy Pharma USA Inc., resulting in updated labeling for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOTOFEN (DIFENOXIN AND ATROPINE SULFATE)

Snippet

SUPPL AP for MOTOFEN (DIFENOXIN AND ATROPINE SULFATE)